Reposted from the College of Engineering. A new grant from the National Institutes of Health will accelerate University of Utah research using biomedical chip technology to better understand keratoconus, a potentially blinding disease that causes the eye's cornea to thin…
BioPharm International FAQ: What FDA’s Individualized Gene Editing Draft Guidance Means for Developers FDA’s draft framework would let sponsors add patient-specific genome editing variants to an approved BLA using in vitro data. Here is what the guidance proposes, what evidence…
Bioengineer.org Machines Join the Hunt for New Schistosomiasis Drugs Subject of Research: How automation and machine learning can accelerate drug discovery for schistosomiasis, a neglected tropical disease treated with a single decades-old drug. Article Title: Automation and machine learning…
Creating a more permissive regulatory framework for precision-bred crops in England is starting to pay dividends as the first crops begin small- and large-scale field trials. While there remains legislation uncertainty and barriers for commercialisation, progress is being made towards…
GenomeWeb Precision BioSciences Aiming to Raise $125M for Gene Therapies
Students, founders, and clinicians gathered at UC Berkeley as we launched the Edge Medicine Innovation Challenge. On September 24, we officially launched the Edge Medicine Innovation Challenge, an open call for seed-stage innovation to impact health at the Edge. Dr. Ida…
Frontiers in Plant Science 6 Epigenetic regulation in the maize plant towards environmental factors and adaptation 8 Gene alteration in maize plants by different factors 9 Beneficial use of phytochemicals found in maize plants in different spheres 12 Conclusion and future directions Front. Plant…
Recently, scientists in Germany at the University of Bonn transformed an 80 year old’s blood cells into 20 year old neural stem cells, reversing around 60 years of aging. This occurred when the Bon… Neurons, created from neural stem cells, born from blood.
German life sciences company Sartorius and McMaster are working together to make it cheaper and more efficient to manufacture medications and drive down patient costs. By William Dorey, Faculty of Engineering November 5, 2026 Inside a 1,600-square-foot research facility, just steps away…
Brian Salmons, Austrianova's CEO added "This publication provides the background and future perspectives for our ongoing collaboration with Avaí Bio through Austrianova announces the publication of a peer-reviewed article on the use of implanted Cell-in-a-Box encapsulated cells for the sustained…
Vaccines, gene therapy, devices, digital health, and clinical breakthroughs.
An article joins this feed when it matches these terms. Each one is also a search of its own.